Research Articles

Alexion Pharmaceuticals: Growth At A Reasonable Price (GARP)

2020-07-10

Research Articles

Introduction I find it very interesting that Alexion Pharmaceuticals Inc. (ALXN) after going public in 2001, did not generate their first profit until December 2008. As we all know, this was in the throes of what is now known as the Great Recession of 2008. Moreover, Alexion’s adjusted operating earnings have grown from $0.20 per […]

FedEx Corp.: Fundamentals Support the Price Increase

2020-07-01

Research Articles

Introduction After reporting better than 4th quarter results on Tuesday, the stock price of FedEx Corp. (FDX) has been on a tear. With this article, I plan to demonstrate that the fundamentals support the current price rise. Moreover, the fundamentals also suggest that it is not too late to take a long-term position in this […]

Demo – FAST Graphs Portfolio Construction Management

2020-06-29

Demos, Research Articles

Anthem (ANTM)

2020-06-24

Research Articles

FAST Graphs Analyze Out Loud on Anthem (ANTM)

Bank of Montréal (BMO)

2020-06-24

Research Articles

FAST Graphs Analyze Out Loud on Bank of Montréal (BMO)

Demo – FUN Graphs: Financial Underlying Numbers

2020-06-24

Demos, Research Articles

In this video Chuck Carnevale, Co-Founder of FAST Graphs will go over FUN Graphs FUN is an acronym for Financial Underlying Numbers. FUN Graphs are designed to empower premium subscribers the capability to quickly and efficiently engage in a comprehensive and deep dive into each company’s historical fundamental results.  There are 4 separate but comprehensive and powerful FUN […]

Unlock data on thousands of companies

Disclaimers: F.A.S.T. Graphs, Inc. is not a broker-dealer or a registered investment adviser. Under no circumstances does any information on Fastgraphs.com constitute a recommendation to buy or sell a security, nor does it give investment advice. This is to include any publications or articles on Fastgraphs.com. Fastgraphs.com is a research tool to be used by its subscribers in conjunction with the subscribers’ additional research and due diligence. The information on this site is in no way guaranteed for completeness or accuracy.